NEW YORK (GenomeWeb News) – Transgenomic shares were down nearly 9 percent in mid-afternoon trading today following the company’s announcement this morning that the chairman of its board of directors, Collin D’Silva, had resigned.
 
Transgenomic shares reached a low of $.65 during the day, down 9.7 percent from their previous close of $.72.
 
D’Silva was a co-founder of Transgenomic and served as president and CEO from 1998 to 2006.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.